Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 18, 2017, Bryan C. Hanson notified Medtronic Public Limited Company (the “Company”) that he would be resigning as the Company’s Executive Vice President and President, Minimally Invasive Therapies Group, effective as of December 18, 2017.
Regulation FD Disclosure.
On December 19, 2017, the Company issued a press release announcing the appointment of Robert J. White, previous Senior Vice President and President of Medtronic’s Asia Pacific (APAC) Region, as Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group (MITG). In addition, the Company announced that Chris Lee, Senior Vice President and President of Medtronic’s Greater China Region, will assume the position of APAC Region President. Lee will remain the interim President of the Greater China Region until a permanent successor is named in the coming weeks. These leadership changes are effective immediately. A copy of the press release is furnished with this Form 8-K as Exhibit 99.1. Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1033, as amended, or the Exchange Act.
(d) List of Exhibits